Suppr超能文献

相似文献

2
TRK inhibitors in TRK fusion-positive cancers.
Ann Oncol. 2019 Nov;30 Suppl 8:viii23-viii30. doi: 10.1093/annonc/mdz282. Epub 2019 Dec 24.
3
Targeting cancer with kinase inhibitors.
J Clin Invest. 2015 May;125(5):1780-9. doi: 10.1172/JCI76094. Epub 2015 May 1.
4
Developmental origins and emerging therapeutic opportunities for childhood cancer.
Nat Med. 2019 Mar;25(3):367-376. doi: 10.1038/s41591-019-0383-9. Epub 2019 Mar 6.
5
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy.
J Pediatr Pharmacol Ther. 2021;26(6):541-555. doi: 10.5863/1551-6776-26.6.541. Epub 2021 Aug 16.
6
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.
Cell Rep. 2018 Apr 3;23(1):227-238.e3. doi: 10.1016/j.celrep.2018.03.050.
7
Emerging Targeted Therapy for Tumors with Fusion Proteins.
Clin Cancer Res. 2018 Dec 1;24(23):5807-5814. doi: 10.1158/1078-0432.CCR-18-1156. Epub 2018 Jul 9.
9
Targeting fusion proteins: a double edge sword?
Expert Opin Ther Targets. 2019 Aug;23(8):651-654. doi: 10.1080/14728222.2019.1628219. Epub 2019 Jun 6.

引用本文的文献

1
FusOn-pLM: a fusion oncoprotein-specific language model via adjusted rate masking.
Nat Commun. 2025 Feb 7;16(1):1436. doi: 10.1038/s41467-025-56745-6.

本文引用的文献

1
The rise of degrader drugs.
Cell Chem Biol. 2023 Aug 17;30(8):864-878. doi: 10.1016/j.chembiol.2023.06.020. Epub 2023 Jul 25.
2
Targeted protein degrader development for cancer: advances, challenges, and opportunities.
Trends Pharmacol Sci. 2023 May;44(5):303-317. doi: 10.1016/j.tips.2023.03.003.
3
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions.
J Med Chem. 2023 Apr 27;66(8):5524-5535. doi: 10.1021/acs.jmedchem.2c01864. Epub 2023 Apr 10.
4
Autologous T cell therapy for MAGE-A4 solid cancers in HLA-A*02 patients: a phase 1 trial.
Nat Med. 2023 Jan;29(1):104-114. doi: 10.1038/s41591-022-02128-z. Epub 2023 Jan 9.
5
Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation.
Genomics Proteomics Bioinformatics. 2022 Oct;20(5):882-898. doi: 10.1016/j.gpb.2022.11.008. Epub 2022 Dec 6.
6
Targeting RNA structures with small molecules.
Nat Rev Drug Discov. 2022 Oct;21(10):736-762. doi: 10.1038/s41573-022-00521-4. Epub 2022 Aug 8.
8
PROTAC targeted protein degraders: the past is prologue.
Nat Rev Drug Discov. 2022 Mar;21(3):181-200. doi: 10.1038/s41573-021-00371-6. Epub 2022 Jan 18.
9
A direct-to-biology high-throughput chemistry approach to reactive fragment screening.
Chem Sci. 2021 Aug 11;12(36):12098-12106. doi: 10.1039/d1sc03551g. eCollection 2021 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验